Axial Spondyloarthritis clinical trials

Explore recruiting axial spondyloarthritis clinical trials.

Recruiting axial spondyloarthritis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Axial Spondyloarthritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Study Participants with Active Axial Spondyloarthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis

Hungary, Poland, France, Belgium, Czechia, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 open-label imaging study to explore the effects of sonelokimab in patients with active axial spondyloarthritis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLANE

Germany, Bulgaria, Poland, Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Detailed assessment of axial and peripheral entheses and joints in axial spondyloarthritis and psoriatic arthritis patients treated with ixekizumab – a 2-year study applying whole-body MRI, MRI-based synthetic CT, and CT

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Rapid pain control in Ixekizumab targeted axial spondyloarthritis

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Axial Spondyloarthritis trials by city

Axial Spondyloarthritis in Toronto Axial Spondyloarthritis in Vancouver Axial Spondyloarthritis in Montreal Axial Spondyloarthritis in Calgary Axial Spondyloarthritis in Edmonton Axial Spondyloarthritis in Ottawa Axial Spondyloarthritis in Winnipeg Axial Spondyloarthritis in Quebec City Axial Spondyloarthritis in Hamilton Axial Spondyloarthritis in Kitchener Axial Spondyloarthritis in London Axial Spondyloarthritis in Halifax Axial Spondyloarthritis in New York Axial Spondyloarthritis in Los Angeles Axial Spondyloarthritis in Chicago Axial Spondyloarthritis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease